Baker Bros. Advisors LP Acrivon Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

  • $9.86 Billion
  • Q2 2025

A detailed history of Baker Bros. Advisors LP transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 22,809 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,809
Previous 22,809 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
N/A
-30,076 Reduced 56.87%
22,809 $0
Q1 2024

May 15, 2024
BUY
N/A
52,885 New
52,885 $0

Others Institutions Holding ACRV

# of Institutions
52
Shares Held
18.4M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email